Option chain shows key data for Allarity Therapeutics's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Allarity Therapeutics.

Allarity Therapeutics (NASDAQ:ALLR) Stock, Option Chain

Allarity Therapeutics

Allarity Therapeutics Inc is a clinical-stage, precision medicine pharmaceutical company focused on developing novel anti-cancer therapeutics for patients with high unmet medical needs. The company is actively advancing the development of stenoparib, an orally available, small-molecule inhibitor for patients with advanced recurrent ovarian cancer. It is leveraging its proprietary Drug Response Predictor (DRP) technology to refine patient selection and improve clinical outcomes. The company operates as a single operating and reporting segment (developing a treatment for ovarian cancer) in two geographic areas: Denmark and the United States.

Wall Street

Analyst Color

Earnings

Equities

Government

Macro Economic Events

Market Summary

News

Broad U.S. Equity ETFs

Guidance

Futures

Treasuries

Economics

Federal Reserve

Pre-Market Outlook

Markets

Analyst Ratings

ETFs

$BTC

ALLR

BIAF

CSAI

MVST

NCNO

NVDA

SONM

SPWH

TSLA

ULBI

XPEV

U.S. stock futures were swinging between gains and losses on Tuesday after a mixed session on Monday. Futures of major benchmark indices were mixed in premarket trading.



President Donald Trump‘s “Liberation Day”, the term he’s used for April 2nd, the day of incoming reciprocal tariffs, preceded a drop in stock prices.

US Stocks Likely To Open Mixed After Disappointing Q1 Performance: &#39;April Does Better After A Weak Q1,&#39; Says Expert

Tesla Rival XPeng Eyes $13.8 Billion Investment In Humanoid Robots, Says Chinese State Media

Trading Ideas

XPeng, Ultralife And 3 Stocks To Watch Heading Into Tuesday

Chi sale e chi scende: i maggiori movimenti nel pre-market di oggi

Movers

EFSH

FRGT

Maxeon Solar Technologies, Ltd. - Ordinary Shares

MAXN

MYNA

OMEX

PGNY

SGLY

SMSI

TBIO

VEEA

VERO

WBUY

XCUR

Why Exicure Shares Are Trading Higher By Around 180%; Here Are 20 Stocks Moving Premarket

Allarity Therapeutics, Inc. - Common stock

Allarity Therapeutics Inc

Allreal Holding Ltd

Penny Stocks

Press Releases

ALLR Shareholders are Encouraged to Join Allarity Therapeutics, Inc. Securities Fraud Investigation with the Schall Law Firm

Allarity Therapeutics Reports Full Year 2024 Financial Results and Provides a Business Update

Allarity Therapeutics Presents Novel Drug Response Predictor—DRP®—for Daratumumab in Multiple Myeloma at AACR 2025

Allarity Therapeutics Provides First Quarter 2025 Update, Highlighting Continued Stenoparib Benefit and Upcoming Trial Enrollment

Allarity Therapeutics Announces Participation in Pharma Partnering Summit US

Allarity Therapeutics Announces First Patient Enrolled in New Phase 2 Clinical Trial Protocol of Stenoparib in Advanced Ovarian Cancer

Allarity Therapeutics Announces Research Collaboration with Indiana Biosciences Research Institute to Further Advance Understanding of Stenoparib's Unique, Dual Therapeutic Mechanism of Action

Allarity Therapeutics Announces Changes to Board of Directors

Allaire Corp

Comments

Allarity Therapeutics

Allarity Therapeutics (ALLR) Options

No option chain data available. Please try again later

Connect With Us

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell